These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22220397)

  • 1. Anti-VEGF in treatment of diabetic macular edema.
    Boras I; Lazić R; Gabrić N; Lukić M; Dekaris I
    Coll Antropol; 2011 Sep; 35 Suppl 2():15-8. PubMed ID: 22220397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-VEGF in treatment of central retinal vein occlusion.
    Lazić R; Boras I; Vlasić M; Gabrić N; Tomić Z
    Coll Antropol; 2010 Apr; 34 Suppl 2():69-72. PubMed ID: 21305727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
    Nguyen QD; Tatlipinar S; Shah SM; Haller JA; Quinlan E; Sung J; Zimmer-Galler I; Do DV; Campochiaro PA
    Am J Ophthalmol; 2006 Dec; 142(6):961-9. PubMed ID: 17046701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
    Santos AR; Gomes SC; Figueira J; Nunes S; Lobo CL; Cunha-Vaz JG
    Ophthalmologica; 2014; 231(1):16-22. PubMed ID: 24280908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
    Gibran SK; Khan K; Jungkim S; Cleary PE
    Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
    Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
    Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.
    Do DV; Nguyen QD; Shah SM; Browning DJ; Haller JA; Chu K; Yang K; Cedarbaum JM; Vitti RL; Ingerman A; Campochiaro PA
    Br J Ophthalmol; 2009 Feb; 93(2):144-9. PubMed ID: 19174400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
    Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
    Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R
    Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone for diffuse diabetic macular oedema.
    Gibran SK; Cullinane A; Jungkim S; Cleary PE
    Eye (Lond); 2006 Jun; 20(6):720-4. PubMed ID: 16021193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab for refractory uveitis-related macular edema.
    Acharya NR; Hong KC; Lee SM
    Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for macular edema secondary to central retinal vein occlusion.
    Risard SM; Pieramici DJ; Rabena MD; Basefsky JC; Avery RL; Castellarin AA; Nasir MA; See RF; Couvillion SS
    Retina; 2011 Jun; 31(6):1060-7. PubMed ID: 21283055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.